Treating Alcohol Use Disorder in Patients with Alcohol Associated Liver Disease.

IF 4.3 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Seminars in liver disease Pub Date : 2022-03-15 DOI:10.1055/a-1798-2872
C. Tarli, A. Mirijello, G. Addolorato
{"title":"Treating Alcohol Use Disorder in Patients with Alcohol Associated Liver Disease.","authors":"C. Tarli, A. Mirijello, G. Addolorato","doi":"10.1055/a-1798-2872","DOIUrl":null,"url":null,"abstract":"Alcohol use disorder (AUD) is one of the main causes of global death and disability. The liver represents the main target of alcohol damage and alcohol associated liver disease (ALD) represents the first cause of liver cirrhosis in Western Countries. Alcohol abstinence is the main goal of treatment in AUD patients with ALD, because treatments for ALD are less effective when drinking continues. Moreover, the persistence of alcohol consumption is associated with higher mortality, increased need for liver transplantation and graft loss. The most effective treatment for AUD is the combination of psychosocial interventions, pharmacological therapy and medical management. However, the effectiveness of these treatments in patients with ALD are doubtful even because AUD patients with ALD are usually excluded from pharmacological trials due to concerns on liver safety. This narrative review will discuss the treatment options for AUD-ALD patients focusing on controversies in pharmacological therapy.","PeriodicalId":21724,"journal":{"name":"Seminars in liver disease","volume":"11 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in liver disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1798-2872","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Alcohol use disorder (AUD) is one of the main causes of global death and disability. The liver represents the main target of alcohol damage and alcohol associated liver disease (ALD) represents the first cause of liver cirrhosis in Western Countries. Alcohol abstinence is the main goal of treatment in AUD patients with ALD, because treatments for ALD are less effective when drinking continues. Moreover, the persistence of alcohol consumption is associated with higher mortality, increased need for liver transplantation and graft loss. The most effective treatment for AUD is the combination of psychosocial interventions, pharmacological therapy and medical management. However, the effectiveness of these treatments in patients with ALD are doubtful even because AUD patients with ALD are usually excluded from pharmacological trials due to concerns on liver safety. This narrative review will discuss the treatment options for AUD-ALD patients focusing on controversies in pharmacological therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
酒精相关性肝病患者酒精使用障碍的治疗
酒精使用障碍(AUD)是全球死亡和残疾的主要原因之一。肝脏是酒精损害的主要目标,酒精相关肝病(ALD)是西方国家肝硬化的首要原因。戒酒是AUD合并ALD患者治疗的主要目标,因为持续饮酒对ALD的治疗效果较差。此外,持续饮酒与更高的死亡率、肝移植需求增加和移植物损失有关。AUD最有效的治疗方法是心理社会干预、药物治疗和医疗管理相结合。然而,这些治疗方法对ALD患者的有效性值得怀疑,因为AUD合并ALD的患者通常出于对肝脏安全的考虑而被排除在药理学试验之外。这篇叙述性综述将讨论AUD-ALD患者的治疗选择,重点是药物治疗方面的争议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Seminars in liver disease
Seminars in liver disease 医学-胃肠肝病学
CiteScore
8.20
自引率
2.40%
发文量
38
期刊介绍: Seminars in Liver Disease is a quarterly review journal that publishes issues related to the specialties of hepatology and gastroenterology. As the premiere review journal in the field, Seminars in Liver Disease provides in-depth coverage with articles and issues focusing on topics such as cirrhosis, transplantation, vascular and coagulation disorders, cytokines, hepatitis B & C, Nonalcoholic Steatosis Syndromes (NASH), pediatric liver diseases, hepatic stem cells, porphyrias as well as a myriad of other diseases related to the liver. Attention is also given to the latest developments in drug therapy along with treatment and current management techniques. Seminars in Liver Disease publishes commissioned reviews. Unsolicited reviews of an exceptional nature or original articles presenting remarkable results will be considered, but case reports will not be published.
期刊最新文献
Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. HBV Biomarkers and Their Role in Guiding Treatment Decisions. Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease. Managing Multiorgan Failure in Acute on Chronic Liver Failure. Advancements in MELD score and its impact in Hepatology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1